Sandbox Reserved 1111

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 10: Line 10:
== Human Psoriasin ==
== Human Psoriasin ==
-
The protein S100A7 is found in the cytoplasm of keratinocytes. S100A7 is highly homologous to S100A15 (koebnerisin) but distinct in expression, tissue distribution and function. The protein has a molecular weight of 23 kDa. The expression of the psoriasin is regulated by different agents. An increase of the cellular amount of calcium also increases the cellular level of S100A7. The UV light increases the expression of the protein. The level of the protein is thought to increase in keratinocytes in response to inflammatory stress. Some studies show that the target protein of the psoriasin could be E-FABP, the epidermal [https://proteopedia.org/wiki/index.php/Fatty_acid-binding_protein fatty acid binding protein]. They proved that E-FABP immobilized on nitrocellulose was able to capture S100A7 and so that those two molecules were probably able to form a complex <ref> Hagens G, Masouyé I, Augsburger E, Hotz R, Saurat JH, Siegenthaler G (April 1999) "Calcium-binding protein S100A7 and epidermal-type fatty acid-binding protein are associated in the cytosol of human keratinocytes" ''Biochem J''. '''339'''(2): 419-427: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220173/</ref>. Fatty acid binding proteins are involved in cellular transports and in the regulation of the solubility of fatty acids <ref> Chmurzyńska A (March 2006). "The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism".''Journal of Applied Genetics''.'''47'''(1): 39-48.https://link.springer.com/article/10.1007/BF03194597</ref>. The biggest difference between the human psoriasin and the rest of the S100 proteins is that the EF-hand at the N-Terminus does not have the ability to bind the calcium <ref> Brodersen DE, Etzerodt M, Madsen P, Celis JE, Thøgersen HC, Nyborg J, Kjeldgaard M (April 1998). "EF-hands at atomic resolution: the structure of human psoriasin(S100A7) solved by MAD phasing". ''Structure''.'''6''': 477-489.https://www.cell.com/structure/pdf/S0969-2126(98)00049-5.pdf</ref>. S100A7 also acts as an anti-microbial protein and it is mainly directed against [https://fr.wikipedia.org/wiki/Escherichia_coli E.Coli]. <ref>Murray J, Boulanger M (April 2010). "S100A7 (S100 calcium binding protein A7)". ''Atlas of Genetics and Cytogeneticsin Oncology and Haematology''. '''15'''(1): 59-64. : http://AtlasGeneticsOncology.org/Genes/S100A7ID42194ch1q21.html</ref>.
+
The protein S100A7 is found in the cytoplasm of keratinocytes and on the chromosome 1q21. S100A7 is highly homologous to S100A15 (koebnerisin) but distinct in expression, tissue distribution and function. The protein has a molecular weight of 23 kDa. The expression of the psoriasin is regulated by different agents. An increase of the cellular amount of calcium also increases the cellular level of S100A7. The UV light increases the expression of the protein. The level of the protein is thought to increase in keratinocytes in response to inflammatory stress. Some studies show that the target protein of the psoriasin could be E-FABP, the epidermal [https://proteopedia.org/wiki/index.php/Fatty_acid-binding_protein fatty acid binding protein]. They proved that E-FABP immobilized on nitrocellulose was able to capture S100A7 and so that those two molecules were probably able to form a complex <ref> Hagens G, Masouyé I, Augsburger E, Hotz R, Saurat JH, Siegenthaler G (April 1999) "Calcium-binding protein S100A7 and epidermal-type fatty acid-binding protein are associated in the cytosol of human keratinocytes" ''Biochem J''. '''339'''(2): 419-427: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220173/</ref>. Fatty acid binding proteins are involved in cellular transports and in the regulation of the solubility of fatty acids <ref> Chmurzyńska A (March 2006). "The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism".''Journal of Applied Genetics''.'''47'''(1): 39-48.https://link.springer.com/article/10.1007/BF03194597</ref>. The biggest difference between the human psoriasin and the rest of the S100 proteins is that the EF-hand at the N-Terminus does not have the ability to bind the calcium <ref> Brodersen DE, Etzerodt M, Madsen P, Celis JE, Thøgersen HC, Nyborg J, Kjeldgaard M (April 1998). "EF-hands at atomic resolution: the structure of human psoriasin(S100A7) solved by MAD phasing". ''Structure''.'''6''': 477-489.https://www.cell.com/structure/pdf/S0969-2126(98)00049-5.pdf</ref>. S100A7 also acts as an anti-microbial protein and it is mainly directed against [https://fr.wikipedia.org/wiki/Escherichia_coli E.Coli]. <ref>Murray J, Boulanger M (April 2010). "S100A7 (S100 calcium binding protein A7)". ''Atlas of Genetics and Cytogeneticsin Oncology and Haematology''. '''15'''(1): 59-64. : http://AtlasGeneticsOncology.org/Genes/S100A7ID42194ch1q21.html</ref>.
== Disease ==
== Disease ==
Line 22: Line 22:
Human psoriasin can be used as antimicrobial petide against E-coli. Some mutant of S100A7 are capable of decrease the survival rate of E. coli mainly. Mutation of the conserved carboxyl-terminal EF-hand calcium-binding motif or heat denaturation slightly reduces S100A7 antibacterial activity. Because it modify the structure of the protein and reduce the affinity with others molecules <ref>KC Lee , RL Eckert (April 2007). "S100A7 (Psoriasin) – Mechanism of Antibacterial Action in Wounds", ''Journal of Investigative Dermatology'' '''127'''(4): 945-957 https://www.sciencedirect.com/science/article/pii/S0022202X15333145 </ref>.
Human psoriasin can be used as antimicrobial petide against E-coli. Some mutant of S100A7 are capable of decrease the survival rate of E. coli mainly. Mutation of the conserved carboxyl-terminal EF-hand calcium-binding motif or heat denaturation slightly reduces S100A7 antibacterial activity. Because it modify the structure of the protein and reduce the affinity with others molecules <ref>KC Lee , RL Eckert (April 2007). "S100A7 (Psoriasin) – Mechanism of Antibacterial Action in Wounds", ''Journal of Investigative Dermatology'' '''127'''(4): 945-957 https://www.sciencedirect.com/science/article/pii/S0022202X15333145 </ref>.
This petide is actually regulated by Caspase-8 using a downregulation of Caspace-8 : mediator of the transcription of the S100A7. This regulation means that less Capase-8 we have more antimicrobial peptide we will get <ref> T Bhatt, A Bhosale, B Bajantri, MS Mathapathi, A Rizvi, G Scita, A Majumdar and C Jamora (November 2019) "Sustained Secretion of the Antimicrobial Peptide S100A7 Is Dependent on the Downregulation of Caspase-8", ''Cell Reports''. '''29'''(9): 2546-2555 https://doi.org/10.1016/j.celrep.2019.10.090 </ref>. [[Image:Caspase8.PNG]]
This petide is actually regulated by Caspase-8 using a downregulation of Caspace-8 : mediator of the transcription of the S100A7. This regulation means that less Capase-8 we have more antimicrobial peptide we will get <ref> T Bhatt, A Bhosale, B Bajantri, MS Mathapathi, A Rizvi, G Scita, A Majumdar and C Jamora (November 2019) "Sustained Secretion of the Antimicrobial Peptide S100A7 Is Dependent on the Downregulation of Caspase-8", ''Cell Reports''. '''29'''(9): 2546-2555 https://doi.org/10.1016/j.celrep.2019.10.090 </ref>. [[Image:Caspase8.PNG]]
 +
 +
The region between the animo acid 35-80 is necessery to have a the full antimicrobial effect this amino acid is the central region of S100A7 protein

Revision as of 21:25, 17 January 2020

This Sandbox is Reserved from 25/11/2019, through 30/9/2020 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1091 through Sandbox Reserved 1115.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

1 PSR

Caption for this structure

Drag the structure with the mouse to rotate

References

  1. Sedaghat F, Notopoulos A (October 2008). "S100 protein family and its application in clinical practice". Hippokratia. 4: 198-204. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2580040/pdf/hippokratia-12-198.pdf
  2. Eckert R, Broome AM, Ruse M, Robinson N, Ryan D, Lee K (July 2004). "S100 Proteins in the Epidermis". Journal of Investigative Dermatology. 123(1): 23-33.https://doi.org/10.1111/j.0022-202X.2004.22719.x
  3. Hagens G, Masouyé I, Augsburger E, Hotz R, Saurat JH, Siegenthaler G (April 1999) "Calcium-binding protein S100A7 and epidermal-type fatty acid-binding protein are associated in the cytosol of human keratinocytes" Biochem J. 339(2): 419-427: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220173/
  4. Chmurzyńska A (March 2006). "The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism".Journal of Applied Genetics.47(1): 39-48.https://link.springer.com/article/10.1007/BF03194597
  5. Brodersen DE, Etzerodt M, Madsen P, Celis JE, Thøgersen HC, Nyborg J, Kjeldgaard M (April 1998). "EF-hands at atomic resolution: the structure of human psoriasin(S100A7) solved by MAD phasing". Structure.6: 477-489.https://www.cell.com/structure/pdf/S0969-2126(98)00049-5.pdf
  6. Murray J, Boulanger M (April 2010). "S100A7 (S100 calcium binding protein A7)". Atlas of Genetics and Cytogeneticsin Oncology and Haematology. 15(1): 59-64. : http://AtlasGeneticsOncology.org/Genes/S100A7ID42194ch1q21.html
  7. S Alowami, G Qing, E Emberley, L Snell & PH Watson (2003). "Psoriasin , (S100A7) expression is altered during skin tumorigenesis" BMC Dermatology.3(1):
  8. AK Ekman, J Vegfors, C Bivik Eding, C Enerbäck (December 2016). "Overexpression of Psoriasin (S100A7) Contributes to Dysregulated Differentiation in Psoriasis", Acta Derm Venereol. 97: https://www.medicaljournals.se/acta/content/html/10.2340/00015555-2596
  9. KC Lee , RL Eckert (April 2007). "S100A7 (Psoriasin) – Mechanism of Antibacterial Action in Wounds", Journal of Investigative Dermatology 127(4): 945-957 https://www.sciencedirect.com/science/article/pii/S0022202X15333145
  10. T Bhatt, A Bhosale, B Bajantri, MS Mathapathi, A Rizvi, G Scita, A Majumdar and C Jamora (November 2019) "Sustained Secretion of the Antimicrobial Peptide S100A7 Is Dependent on the Downregulation of Caspase-8", Cell Reports. 29(9): 2546-2555 https://doi.org/10.1016/j.celrep.2019.10.090
Personal tools